Tag Archives: Treatment

Melatonin as a Potential Treatment for SARS-CoV-2

More than 140 scientific studies suggest melatonin is a useful agent for treating SARS-CoV-2, according to research published in Cellular and Molecular Life Sciences.1 Despite this, and its known antiviral and anti-inflammatory effects, melatonin has received little attention as a countermeasure for COVID-19. After reviewing the published literature related to melatonin and SARS-CoV-2/COVID-19 in November… Read More »

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

Steroids Are Not an Effective Treatment for COVID-19 Smell Loss

According to researchers, steroids shouldn’t be used for treating smell loss due to Covid-19. The loss of smell is a well known Covid-19 symptom, and many individuals are left with long-term smell loss from the pandemic. Researchers have found that corticosteroids, a type of drug that reduces inflammation, aren’t recommended for treating loss of smell… Read More »

Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment

A qualitative study sought to understand healthcare workers’ perspectives on patients who disengage from antiretroviral therapy (ART) at a clinic in Cape Town, South Africa. Results, presented this week to the 11th International AIDS Society Conference on HIV Science (IAS 2021) showed that healthcare workers had contradictory feelings about these patients, ranging from empathy to… Read More »

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

Gaining weight after switching to a new antiretroviral combination is common, especially after switching from efavirenz or the older formulation of tenofovir, but most weight gain is modest and occurs in the first year after switching, a review of 12 large clinical trials shows. The results suggest that some older antiretrovirals may have a weight-suppressive… Read More »